Segment Reporting

3 Months Ended

Mar. 31, 2012

12. Segment Reporting. The Company has four reportable segments: Life Sciences, Healthcare, Physician and IT and Engineering. The Company's management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments' internal financial reporting used for corporate management purposes.

The following table presents revenues, gross profit and operating income by reportable segment (in thousands):

	Three Months Ended
	March 31,
	2012			2011
Revenues:
Life Sciences	$	41,351		$	32,957
Healthcare		22,879			19,844
Physician		24,089			16,518
IT and Engineering		78,759			60,119
Total Revenues	$	167,078		$	129,438
Gross Profit:
Life Sciences	$	13,839		$	11,270
Healthcare		6,340			5,627
Physician		7,499			5,299
IT and Engineering		27,370			20,958
Total Gross Profit	$	55,048		$	43,154
Operating Income (Loss):
Life Sciences	$	2,308		$	1,461
Healthcare		(674	)		(1,667	)
Physician		1,078			631
IT and Engineering		7,235			5,974
Total Operating Income	$	9,947		$	6,399

The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents revenues by geographic location (in thousands):

	Three Months Ended
	March 31,
	2012		2011
Revenues:
Domestic	$	147,762	$	116,285
Foreign		19,316		13,153
Total Revenues	$	167,078	$	129,438

The Company does not report Life Sciences and Healthcare segments' total assets separately as the operations are largely centralized. The following table presents total assets as allocated by reportable segment (in thousands):

	March 31, 2012		December 31, 2011
Total Assets:
Life Sciences and Healthcare	$	111,282	$	107,915
Physician		84,206		83,940
IT and Engineering		224,501		218,810
Total Assets	$	419,989	$	410,665